Meta-analysis for genome-wide association studies using case-control design: application and practice

Abstract

This review aimed to arrange the process of a systematic review of genome-wide association studies in order to practice and apply a genome-wide meta-analysis (GWMA). The process has a series of five steps: searching and selection, extraction of related information, evaluation of validity, meta-analysis by type of genetic model, and evaluation of heterogeneity. In contrast to intervention meta-analyses, GWMA has to evaluate the Hardy–Weinberg equilibrium (HWE) in the third step and conduct meta-analyses by five potential genetic models, including dominant, recessive, homozygote contrast, heterozygote contrast, and allelic contrast in the fourth step. The ‘genhwcci’ and ‘metan’ commands of STATA software evaluate the HWE and calculate a summary effect size, respectively. A meta-regression using the ‘metareg’ command of STATA should be conducted to evaluate related factors of heterogeneities.

Genetic Variants Associated With Response to Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients: A Field Synopsis and Meta‐Analysis

“…This led to variations in the number of studies included in our metaanalysis for the different genetic models. This methodology is consistent with standard practices in the field of meta-analysis of genetic association studies [24]. Conventional comparisons from publications were used to evaluate the effects of genetic variants that were not single nucleotide polymorphisms (e.g., GSTM1 [null vs. present]).…”

Associations between TLR4 Polymorphisms and Open Angle Glaucoma: A Meta-Analysis

“…A p-value < 0.05 was considered significant for statistical analysis. The allelic model (2 vs. 1), dominant model (22+12 vs. 11), and recessive model (22 vs. 12+11) were calculated to evaluate the association between TLR4 polymorphisms and OAG [24]. In order to detect potential publication bias, Begg's and Egger's tests were calculated using Stata (version 14; StataCorp, College Station, Texas).…”

Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association

“…• Combining summary statistics across analyses via meta-analysis is a common approach for both rare and common variant analyses. Special considerations in genomic meta-analyses, [74][75][76] and transethnic meta-analyses 77 in particular include detailed examination of effect heterogeneity, linkage disequilibrium differences across studies, effect masking attributable to epistasis (particularly in populations of recent African descent), and conditional analyses to uncover novel variants in established risk-association regions of the genome. Special attention should also be given to the sampling framework and ascertainment strategies of contributing studies and the effects that these study designs may have on downstream combined and meta-analyses.…”